NCT06804954

Brief Summary

The goal of this randomized controlled trial is to investigate if online transdiagnostic cognitive behavior therapy (CBT) can be effective in the treatment of subsyndromal mental ill-health in adult primary care patients. The main aim is to investigate: if online transdiagnostic CBT yields superior symptomatic improvement compared to care-as-usual when given in a primary care context to patients with mental ill-health. Researchers will compare online transdiagnostic CBT to primary care as usual to see if psychiatric symptoms can be reduced. Participants will be randomized to online transdiagnostic CBT or primary care as usual. Participants in online transdiagnostic CBT will receive a cognitive behavioral treatment provided through a secure web platform in which psychoeducation, worksheets, and exercises are presented in online modules similar to chapters in a book. Participants will receive weekly written feedback on their work and progress by a therapist who gives gradual access to the treatment modules. The lion's share of the contact between the therapist and the patient thus takes place through messages (similar to email) in the online treatment platform. Participants randomized to care as usual will receive health care services as usual in primary care. As this comparator is intended to reflect real routine primary care, the interventions will not be controlled by the research project, but the investigators expect that participants will receive an active treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started Feb 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Feb 2025Feb 2029

First Submitted

Initial submission to the registry

January 28, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 3, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

February 25, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2029

Last Updated

March 7, 2025

Status Verified

February 1, 2025

Enrollment Period

4 years

First QC Date

January 28, 2025

Last Update Submit

March 5, 2025

Conditions

Keywords

Primary CareTransdiagnostic CBTOnline treatmentSubsyndromal mental ill-health

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in Depression Anxiety Stress Scales-21 (DASS-21) to 10-week, and 1-and 2- year follow-ups

    This is a 21-item scale with a sum score range 0 to 126 where a higher score indicates more symptoms.

    Baseline, weeks 2, 4, 6, 8, 10 (primary endpoint), and 1-and 2-year follow-up

Secondary Outcomes (5)

  • Change in WHODAS from baseline to 10-week, and 1- and 2-year follow-ups

    Baseline, week 10, 1- and 2-year follow-ups

  • Change in Work Ability Index from baseline to 10-week, and 1- and 2-year follow-ups

    Baseline, week 10, 1- and 2-year follow-ups

  • Change in Brunnsviken Brief Quality of Life Index from baseline to 10-week, and 1- and 2-year follow-ups

    Baseline, week 10, 1- and 2-year follow-ups

  • Change in sickness absence from 1 year before baseline to 1- and 2-year follow-ups

    The 1-year period preceding baseline, 1- and 2-year periods after baseline

  • Change in EPQR-A Neuroticism scale from baseline to 10-week, and 1-and 2-year follow-ups

    Baseline, week 10, 1- and 2-year follow-ups

Other Outcomes (11)

  • Client Satisfaction Questionnaire at 10-week follow-up

    10-week follow-up

  • Negative Effects Questionnaire at 10-week follow-up

    10-week follow-up

  • Credibility Scale (C-scale) 2 weeks after baseline

    2 weeks after baseline

  • +8 more other outcomes

Study Arms (2)

Online transdiagnostic CBT

EXPERIMENTAL

Participants randomized to this arm will receive the intervention online transdiagnostic CBT (see Interventions).

Behavioral: Online transdiagnostic CBT

Primary care as usual

ACTIVE COMPARATOR

Patients randomized to this study condition will receive health care services as usual in primary care.

Other: Primary care as usual

Interventions

This treatment is provided through a secure web platform in which psychoeducation, worksheets, and exercises are presented in online modules similar to chapters in a book. Participants will receive weekly written feedback on their work and progress by a therapist who gives gradual access to the treatment modules. The lion's share of the contact between the therapist and the patient thus takes place through messages (similar to email) in the online treatment platform. It is however allowed to also have one to three face-to-face sessions on-site or through video calls to provide technical assistance and therapeutic support in accordance with the treatment model. Core components are: (a) psychoeducation about emotions and CBT, (b) functional analysis, (c) mindfulness practice, (d) breaking dysfunctional emotion-driven behaviors, and (e) exposure exercises.

Online transdiagnostic CBT

It is mandatory for primary care services in Stockholm, Sweden, to have staff with adequate competence in the assessment and treatment of common mental disorders. Typically, these patients are handled by general practitioners, psychologists, nurses, or social workers. As this comparator is intended to reflect real routine primary care, the interventions will not be controlled by the research project. We expect that participants allocated to this condition will receive an active treatment.

Primary care as usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be included patients have to:
  • To be included patients have to: (a) have a subsyndromal mental health problem concerning anxiety, depressive symptoms, or stress-related ill-health that warrants treatment,
  • be at least 18 years old,
  • have regular access to a device with an Internet connection,
  • be able to read and write in Swedish,
  • have no severe psychiatric disorder that requires specialized psychiatric care, such as psychosis, bipolar disorder, or anorexia nervosa,
  • if on medication with monoamine agonist, have stable dosage in the past month,
  • have no on-going psychological treatment, and
  • provide written informed consent for participation and complete baseline assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Region Stockholm, Gustavsberg Primary Care Center

Gustavsberg, Stockholm County, 134 40, Sweden

RECRUITING

MeSH Terms

Interventions

Primary Health Care

Intervention Hierarchy (Ancestors)

Comprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Erik Hedman-Lagerlöf, PhD, professor

    Region Stockholm and Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, PhD

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 3, 2025

Study Start

February 25, 2025

Primary Completion (Estimated)

February 6, 2029

Study Completion (Estimated)

February 6, 2029

Last Updated

March 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

The information collected in the study contains sensitive personal data and is protected by Swedish and European data secrecy regulations. Any data sharing is thus subject to assessment by relevant authorities and is not something the principal investigator can decide upon.

Locations